Thompson Davis & Co’s Cardiovascular Systems, Inc. CSII Stock Holding History

Thompson Davis & Co’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$64K	Sell	1,625 -125	-7%	-$4.62K	0.14%	159
2018 Q2	$57K	Sell	1,750 -125	-7%	-$3.44K	0.14%	169
2018 Q1	$41K	Buy	+1,875	New	+$45.1K	0.11%	195
2015 Q3	–	Sell	-1,750	Closed	-$46K	–	1270
2015 Q2	$46K	Sell	1,750 -750	-30%	-$24.2K	0.05%	324
2015 Q1	$98K	Hold	2,500	–	–	0.12%	185
2014 Q4	$75K	Sell	2,500 -250	-9%	-$7.15K	0.09%	219
2014 Q3	$65K	Sell	2,750 -250	-8%	-$7.11K	0.08%	230
2014 Q2	$93K	Buy	3,000 +375	+14%	+$10.8K	0.13%	184
2014 Q1	$83K	Sell	2,625 -375	-13%	-$12.4K	0.14%	184
2013 Q4	$103K	Buy	+3,000	New	+$87.3K	0.16%	149

Other funds holding CSII

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Thompson Davis & Co's CSII Position: Q3 2018 in Review

Thompson Davis & Co reduced its Cardiovascular Systems, Inc. (CSII) stake by 7.1% in Q3 2018, selling an estimated $4.62K and leaving 1,625 shares worth $64K. The position accounts for 0.14% of the portfolio, ranked #159.

Thompson Davis & Co first reported a position in CSII in Q4 2013 and has held it in 10 quarters since. The position peaked at $103K in Q4 2013. 159 funds tracked by Wall St. Rank hold CSII as of Q3 2018.

Thompson Davis & Co held 1,625 shares of Cardiovascular Systems, Inc. worth $64K as of Q3 2018.
Thompson Davis & Co sold 125 Cardiovascular Systems, Inc. shares in Q3 2018, an estimated $4.62K.
Cardiovascular Systems, Inc. made up 0.14% of Thompson Davis & Co's portfolio in Q3 2018, its #159 holding.
Thompson Davis & Co first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and has held it in 10 quarters since.
Thompson Davis & Co's Cardiovascular Systems, Inc. position peaked at $103K in Q4 2013.
159 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.